Gladius Capital Management LP Theravance Biopharma, Inc. Transaction History

Gladius Capital Management LP

  • $166 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Dec 18, 2023
BUY
$9.87 - $11.44 $31,485 - $36,493
3,190 New
3,190 $34,000
Q1 2023

May 09, 2023
SELL
$9.87 - $11.44 $3,582 - $4,152
-363 Reduced 10.22%
3,190 $35,000
Q4 2022

Dec 18, 2023
BUY
$9.65 - $11.34 $34,286 - $40,291
3,553 New
3,553 $39,000
Q4 2022

Feb 02, 2023
BUY
$9.65 - $11.34 $34,286 - $40,291
3,553 New
3,553 $40,000

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $666M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email